Mrs
Dr
Miss
Ms
Prof
Printer Friendly
Printed from http://www.researchandmarkets.com/reports/2113805
Astellas Pharma Inc. - Strategy and SWOT Report
Description:
Astellas Pharma Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. Astellas Pharma Inc. - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Astellas Pharma (Astellas) is engaged in the manufacturing, marketing, import and export of pharmaceuticals and related products. The company primarily operates in Japan, and has 64 subsidiaries and three associated companies. It is headquartered in Tokyo, Japan and employed 16,279 people as of March 31, 2011. The company recorded revenues of JPY953,948 million ($11,161.2 million-) during the financial year ended March 2011 (FY2011), a decrease of 2.1% over FY2010. The operating profit of the company was JPY119,181 million ($1,394.4 million-) during FY2011, a decrease of 36.1% over FY2010. The net profit was JPY67,651 million ($791.5 million-) in FY2011, a decrease of 44.7% over FY2010. -Calculated using the constant conversion rate of JPY1 = $0.0117 for the financial year ended March 31, 2011.
Scope of the Report
- Provides all the crucial information on Astellas Pharma Inc. required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting Astellas Pharma Inc. in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Astellas Pharma Inc.
-Data is supplemented with details on Astellas Pharma Inc. history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Astellas Pharma Inc.
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Understand prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
Astellas Pharma (Astellas) is engaged in the manufacturing, marketing, import and export of pharmaceuticals and related products. The company primarily operates in Japan, and has 64 subsidiaries and three associated companies. It is headquartered in Tokyo, Japan and employed 16,279 people as of March 31, 2011. The company recorded revenues of JPY953,948 million ($11,161.2 million-) during the financial year ended March 2011 (FY2011), a decrease of 2.1% over FY2010. The operating profit of the company was JPY119,181 million ($1,394.4 million-) during FY2011, a decrease of 36.1% over FY2010. The net profit was JPY67,651 million ($791.5 million-) in FY2011, a decrease of 44.7% over FY2010. -Calculated using the constant conversion rate of JPY1 = $0.0117 for the financial year ended March 31, 2011.
Scope of the Report
- Provides all the crucial information on Astellas Pharma Inc. required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting Astellas Pharma Inc. in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Astellas Pharma Inc.
-Data is supplemented with details on Astellas Pharma Inc. history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Astellas Pharma Inc.
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Understand prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
Contents:
Company Snapshot
Astellas Pharma Inc.: Company Overview
Astellas Pharma Inc.: Overview and Key Facts
Astellas Pharma Inc.: Overview
Astellas Pharma Inc.: Key Facts
Astellas Pharma Inc.: Key Employees
Astellas Pharma Inc.: Key Employee Biographies
Astellas Pharma Inc.: Major Products and Services
Astellas Pharma Inc.: Company History
Astellas Pharma Inc.: Management Statement
Astellas Pharma Inc.: Locations and Subsidiaries
Astellas Pharma Inc.: Key Competitors
Astellas Pharma Inc.: Company Analysis
Astellas Pharma Inc.: Business Description
Astellas Pharma Inc.: SWOT Analysis
Astellas Pharma Inc.: SWOT Overview
Astellas Pharma Inc.: Strengths
Astellas Pharma Inc.: Weaknesses
Astellas Pharma Inc.: Opportunities
Astellas Pharma Inc.: Threats
Astellas Pharma Inc.: Corporate Financial Deals Activity
Astellas Pharma Inc.: Financial Deals Overview
Astellas Pharma Inc.: Targets and Partners
Astellas Pharma Inc.: Top Deals 2007 -YTD-2012
Astellas Pharma Inc.: Advisors
Astellas Pharma Inc.: Top Legal Advisors
Astellas Pharma Inc.: Top Financial Advisors
Astellas Pharma Inc.: Mergers and Acquisitions
Astellas Pharma Inc.: Corporate Venturing
Astellas Pharma Inc.: Partnership
Astellas Pharma Inc.: Divestments
Astellas Pharma Inc.: Recent Developments
Astellas Pharma Inc.: News and Events Summary
Astellas Pharma Inc.: Contracts
Astellas Pharma Inc.: Corporate Governance
Astellas Pharma Inc.: Financial Deals
Astellas Pharma Inc.: Regulatory and Legal Events
Astellas Pharma Inc.: Research & Development
Astellas Pharma Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About Datamonitor
List of Tables
Table 1: Astellas Pharma Inc.: Key Facts
Table 2: Astellas Pharma Inc.: Key Employees
Table 4: Astellas Pharma Inc.: Key Competitors
Table 5: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (TTM)
Table 6: Astellas Pharma Inc.: M&A Activity by Geography (TTM)
Table 7: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (2008 - YTD-2012)
Table 8: Astellas Pharma Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Astellas Pharma Inc.: Targets and Partners
Table 10: Astellas Pharma Inc.: Top Deals 2007 -YTD-2012
Table 11: Astellas Pharma Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Astellas Pharma Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Astellas Pharma Inc.: M&A Volume and Value Trend (2008 - YTD-2012)
Table 14: Astellas Pharma Inc.: M&A Activity by Geography (2008 - YTD-2012)
Table 15: Astellas Pharma Inc.: Corporate Venturing Volume and Value Trend (2008 - YTD-2012)
Table 16: Astellas Pharma Inc.: Corporate Venturing by Geography (2008 - YTD-2012)
Table 17: Astellas Pharma Inc.: Partnership Volume and Value Trend (2008 - YTD-2012)
Table 18: Astellas Pharma Inc.: Partnership Trend by Deal Type (2008 - YTD-2012)
Table 19: Astellas Pharma Inc.: Divestments Volume and Value Trend (2008 - YTD-2012)
Table 20: Astellas Pharma Inc.: Divestments by Geography (2008 - YTD-2012)
Table 21: Astellas Pharma Inc.: News and Events Summary
Table 22: Astellas Pharma Inc.: Contracts
Table 23: Astellas Pharma Inc.: Corporate Governance
Table 24: Astellas Pharma Inc.: Financial Deals
Table 25: Astellas Pharma Inc.: Regulatory and Legal Events
Table 26: Astellas Pharma Inc.: Research & Development
Table 27: Astellas Pharma Inc.: Strategy and Operations
List of Figures
Figure 1: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (TTM)
Figure 2: Astellas Pharma Inc.: M&A Activity by Geography (TTM)
Figure 3: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (2008 - YTD-2012)
Figure 4: Astellas Pharma Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: Astellas Pharma Inc.: M&A Volume and Value Trend (2008 - YTD-2012)
Figure 6: Astellas Pharma Inc.: M&A Activity by Geography (2008 - YTD-2012)
Figure 7: Astellas Pharma Inc.: Corporate Venturing Volume and Value Trend (2008 - YTD-2012)
Figure 8: Astellas Pharma Inc.: Corporate Venturing by Geography (2008 - YTD-2012)
Figure 9: Astellas Pharma Inc.: Partnership Volume and Value Trend (2008 - YTD-2012)
Figure 10: Astellas Pharma Inc.: Partnership Trend by Deal Type (2008 - YTD-2012)
Figure 11: Astellas Pharma Inc.: Divestments Volume and Value Trend (2008 - YTD-2012)
Figure 12: Astellas Pharma Inc.: Divestments by Geography (2008 - YTD-2012)
Astellas Pharma Inc.: Company Overview
Astellas Pharma Inc.: Overview and Key Facts
Astellas Pharma Inc.: Overview
Astellas Pharma Inc.: Key Facts
Astellas Pharma Inc.: Key Employees
Astellas Pharma Inc.: Key Employee Biographies
Astellas Pharma Inc.: Major Products and Services
Astellas Pharma Inc.: Company History
Astellas Pharma Inc.: Management Statement
Astellas Pharma Inc.: Locations and Subsidiaries
Astellas Pharma Inc.: Key Competitors
Astellas Pharma Inc.: Company Analysis
Astellas Pharma Inc.: Business Description
Astellas Pharma Inc.: SWOT Analysis
Astellas Pharma Inc.: SWOT Overview
Astellas Pharma Inc.: Strengths
Astellas Pharma Inc.: Weaknesses
Astellas Pharma Inc.: Opportunities
Astellas Pharma Inc.: Threats
Astellas Pharma Inc.: Corporate Financial Deals Activity
Astellas Pharma Inc.: Financial Deals Overview
Astellas Pharma Inc.: Targets and Partners
Astellas Pharma Inc.: Top Deals 2007 -YTD-2012
Astellas Pharma Inc.: Advisors
Astellas Pharma Inc.: Top Legal Advisors
Astellas Pharma Inc.: Top Financial Advisors
Astellas Pharma Inc.: Mergers and Acquisitions
Astellas Pharma Inc.: Corporate Venturing
Astellas Pharma Inc.: Partnership
Astellas Pharma Inc.: Divestments
Astellas Pharma Inc.: Recent Developments
Astellas Pharma Inc.: News and Events Summary
Astellas Pharma Inc.: Contracts
Astellas Pharma Inc.: Corporate Governance
Astellas Pharma Inc.: Financial Deals
Astellas Pharma Inc.: Regulatory and Legal Events
Astellas Pharma Inc.: Research & Development
Astellas Pharma Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About Datamonitor
List of Tables
Table 1: Astellas Pharma Inc.: Key Facts
Table 2: Astellas Pharma Inc.: Key Employees
Table 4: Astellas Pharma Inc.: Key Competitors
Table 5: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (TTM)
Table 6: Astellas Pharma Inc.: M&A Activity by Geography (TTM)
Table 7: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (2008 - YTD-2012)
Table 8: Astellas Pharma Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Astellas Pharma Inc.: Targets and Partners
Table 10: Astellas Pharma Inc.: Top Deals 2007 -YTD-2012
Table 11: Astellas Pharma Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Astellas Pharma Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Astellas Pharma Inc.: M&A Volume and Value Trend (2008 - YTD-2012)
Table 14: Astellas Pharma Inc.: M&A Activity by Geography (2008 - YTD-2012)
Table 15: Astellas Pharma Inc.: Corporate Venturing Volume and Value Trend (2008 - YTD-2012)
Table 16: Astellas Pharma Inc.: Corporate Venturing by Geography (2008 - YTD-2012)
Table 17: Astellas Pharma Inc.: Partnership Volume and Value Trend (2008 - YTD-2012)
Table 18: Astellas Pharma Inc.: Partnership Trend by Deal Type (2008 - YTD-2012)
Table 19: Astellas Pharma Inc.: Divestments Volume and Value Trend (2008 - YTD-2012)
Table 20: Astellas Pharma Inc.: Divestments by Geography (2008 - YTD-2012)
Table 21: Astellas Pharma Inc.: News and Events Summary
Table 22: Astellas Pharma Inc.: Contracts
Table 23: Astellas Pharma Inc.: Corporate Governance
Table 24: Astellas Pharma Inc.: Financial Deals
Table 25: Astellas Pharma Inc.: Regulatory and Legal Events
Table 26: Astellas Pharma Inc.: Research & Development
Table 27: Astellas Pharma Inc.: Strategy and Operations
List of Figures
Figure 1: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (TTM)
Figure 2: Astellas Pharma Inc.: M&A Activity by Geography (TTM)
Figure 3: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (2008 - YTD-2012)
Figure 4: Astellas Pharma Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: Astellas Pharma Inc.: M&A Volume and Value Trend (2008 - YTD-2012)
Figure 6: Astellas Pharma Inc.: M&A Activity by Geography (2008 - YTD-2012)
Figure 7: Astellas Pharma Inc.: Corporate Venturing Volume and Value Trend (2008 - YTD-2012)
Figure 8: Astellas Pharma Inc.: Corporate Venturing by Geography (2008 - YTD-2012)
Figure 9: Astellas Pharma Inc.: Partnership Volume and Value Trend (2008 - YTD-2012)
Figure 10: Astellas Pharma Inc.: Partnership Trend by Deal Type (2008 - YTD-2012)
Figure 11: Astellas Pharma Inc.: Divestments Volume and Value Trend (2008 - YTD-2012)
Figure 12: Astellas Pharma Inc.: Divestments by Geography (2008 - YTD-2012)
Ordering:
Order Online - visit http://www.researchandmarkets.com/reports/2113805
Order by Fax - using the order form below
Order By Post - print the order form below and send to
Order by Fax - using the order form below
Order By Post - print the order form below and send to
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
Page 1 of 2
Printed Wednesday, June 19, 2013
10:16:12 PM
10:16:12 PM
Fax order form
To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net
Order information
Please verify that the product information is correct and select the format you require.
Product name
Astellas Pharma Inc. - Strategy and SWOT Report
Web Address
http://www.researchandmarkets.com/reports/2113805
Office Code
OC8DIQQLURQTPQ
Report Formats
Please enter the quantity of the report format you require.
| Format | Quantity | Price |
|---|---|---|
| Electronic (PDF) - Enterprisewide |
|
EUR 335 |
| Electronic (PDF) - Single User |
|
EUR 134 |
Contact information
Please enter all the information below in block capitals.
Title:
Mr
Mrs
Dr
Miss
Ms
Prof
Mrs
Dr
Miss
Ms
Prof
First Name:
Last Name:
Email Address:
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:
Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Page 2 of 2
Printed Wednesday, June 19, 2013
10:16:12 PM
10:16:12 PM
Payment information
Please indicate the payment method you would like to use by selecting the appropriate box.
Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date:
/
Card Number:
CVV Security Code:
Issue date:
/ (Diners Club only)
Pay by Check:
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
Pay by Wire Transfer:
Please transfer funds to:
Account Number:
83313083
Sort Code:
98-53-30
Swift Code:
ULSBIE2D
IBAN Number:
IE78ULSB98533083313083
Bank Address:
Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp